Intravitreal toxicity of ketorolac tris salt and flurbiprofen

Ophthalmic Surgery Lasers and Imaging

Volumn 40, Issue 1, 2009, Pages 38-42

  Morales, Ana Munoz ^a   Kivilcim, Muhamet ^a   Peyman, Gholam A ^b,c   Main, Muhammad ^b   De Almada Manzano, Roberta Pereira ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLURBIPROFEN; KETOROLAC TROMETAMOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; ELECTRORETINOGRAPHY; EYE TOXICITY; HISTOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RABBIT; RETINA DISEASE; TOXICITY TESTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; ELECTRORETINOGRAPHY; FLURBIPROFEN; KETOROLAC TROMETHAMINE; OPHTHALMOSCOPY; RABBITS; RETINA; VITREOUS BODY;

EID: 59449107593     PISSN: 15428877     EISSN: None     Source Type: Journal    
DOI: 10.3928/15428877-20090101-14     Document Type: Article

References (27)

1. Weinreb RN, Polansky JR, Alvarado JA, Mitchell MD. Arachidonic acid metabolism in human trabecular mesh-work cells. Invest Ophthalmol Vis Sci. 1998;29:1708-1712.
2. Rho DS. Treatment of acute pseudophakic cystoid macular edema: diclofenac versus ketorolac. J Cataract Refract Surg. 2003;29:2378-2384.
3. Flach AJ. Topical nonsteroidal antiinflammatory drugs in ophthalmology. Int Ophthalmol Clin. 2002;42:1-11.
4. Sivaprasad S, Bunce C, Patel N. Non-steroidal anti-inflammatory agents for treating cystoid macular edema following cataract surgery. Cochrane Database Syst Rev. 2005;Jan 25 (1):CD004239.
5. Srinivasan R, Madhavaranga. Topical ketorolac tro-methamine 0.5% versus diclofenac sodium 0.1% to inhibit miosis during cataract surgery. J Cataract Refract Surg. 2002;28:517-520.
6. Zhu X, Conklin DR, Eisenach JC. Preoperative inhibition of cyclooxygenase-1 in the spinal cord reduces postoperative pain. Anesth Analg. 2005;100:1390-1393.
7. Chowdhury B, Adak M, Bose SK. Flurbiprofen: a unique non-steroidal anti-inflammatory drug with antimicrobial activity against Trichophyton, Microspo-rum and Epidermophyton species. Lett Appl Microbiol. 2003;37:158-161.
8. Price MO, Price FW. Efficacy of topical ketorolac tro-methamine 0.4% for control of pain or discomfort associated with cataract surgery. Curr Med Res Opin. 2004;20:2015-2019.
9. Simone JN, Pendelton RA, Jenkins JE. Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery. J Cataract Refract Surg. 1999;25:699-704.
10. Leonardi A, Busato F, Fregona I, Plebani M, Secchi AG. Anti-inflammatory and antiallergic effects of ketorolac tromethamine in the conjunctival provocation model. Br J Ophthalmol. 2000;84:1228-1232.
11. Flach AJ, Stegman RC, Graham J, Kruger LP. Prophylaxis of aphakic cystoid macular edema without corticosteroids: a paired-comparison, placebo-controlled double-masked study. Ophthalmology. 1990;97:1253-1258.
12. Flach AJ, Jampol LM, Weinberg D, et al. Improvement in visual acuity in chronic aphakic and pseudopha-kic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine. Am J Ophthalmol. 1991;112:514-519.
13. Snyder RW, Siekert RW, Schwiegerling J, Donnenfeld E, Thompson P. Acular as a single agent for use as an antimiotic and anti-inflammatory in cataract surgery. J Cataract Refract Surg. 2000;26:1225-1227.
14. Alam CA, Seed MP, Willoughby DA. Angiostasis and vascular regression in chronic granulomatous inflammation induced by diclofenac in combination with hyaluronan in mice. J Pharm Pharmacol. 1995;47:407-411.
15. Seed MP, Freemantle CN, Alam CA, et al. Apoptosis induction and inhibition of colon-26 tumour growth and angiogenesis: findings on COX-1 and COX-2 inhibitors in vitro and in vivo and topical diclofenac in hyaluronan. Adv Exp Med Biol. 1997;433:339-342.
16. Shen WY, Constable IJ, Chelva E, Rakoczy PE. Inhibition of diclofenac formulated in hyaluronan on angio-genesis in vitro and its intraocular tolerance in the rabbit eye. Graefes Arch Clin Exp Ophthalmol. 2000;238:273-282.
17. Kim SJ, Adams NA, Toma HS, et al. Safety of intra-vitreal ketorolac and diclofenac: an electroretinographic and histopathologic study. Retina. 2008;28:595-605.
18. Phillips AF, Hayashi S, Seitz B, Wee WR, McDonnell PJ. Effect of diclofenac, ketorolac, and fluorometholone on arachidonic acid metabolites following excimer laser corneal surgery. Arch Ophthalmol. 1996;114:1495-1498.
19. Cuevas Andres R, Ruiz Moreno O, Ferrer Novella E, et al. Study of topical ketorolac effect on arachidonic acid metabolism in experimental anterior uveitis. Arch Soc Esp Oftalmol. 2000;75:443-448.
20. Naveh N, Peer J, Bartov E, Weissman C. Argon laser irradiation of rabbits' eyes: changes in prostaglandin E2 levels. Prostaglandins. 1991;41:143-155.
21. Dastgheib K, Green WR. Granulomatous reaction to Bruch's membrane in age-related macular degeneration. Arch Ophthalmol. 1994;112:813-818.
22. Penfold PL, Madigan MC, Gillies MC, Provis JM. Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res. 2001;20:385-414.
23. Flach AJ. Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs. Trans Am Ophthalmol Soc. 2001;99:205-210.
24. Congdon NG, Schein OD, von Kulajta P, Lubomski LH, Gilbert D, Katz J. Corneal complications associated with topical ophthalmic use of nonsteroidal anti-inflammatory drugs. J Cataract Refract Surg. 2001;27:622-631.
25. Singal N, Hopkins J. Pseudophakic cystoid macular edema: ketorolac alone vs. ketorolac plus prednisolone. Can J Ophthalmol. 2004;39:245-250.
26. Lee MS, Lass JH. Rapid response of cystoid macular edema related to Nd:YAG laser capsulotomy to 0.5% ketorolac. Ophthalmic Surg Lasers Imaging. 2004:35:162-164.
27. Hirneiss C, Neubauer AS, Kampik A, Schonfeld CL. Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study. Grae-fes Arch Clin Exp Ophthalmol. 2005;243:768-773.